Nephrotic syndrome; is rituximab the light at the end of the tunnel in the treatment of adult steroid-dependent minimal change disease and focal segmental glomerulosclerosis? - Andreas Kronbichler; Gert Mayer (Society of Diabetic Nephropathy Prevention, 2014)